Retinal Neovascularization Clinical Trial
— SITE-AppOfficial title:
Intravitreal Injections With Avastin in Proliferative Retinopathies Related to the Production of VEGF Having Different Causes
Verified date | June 2008 |
Source | Ophthalmological Association Edelweiss |
Contact | n/a |
Is FDA regulated | No |
Health authority | Romania: Ministry of Public Health |
Study type | Interventional |
The study intends to assess the effect of Avastin injections in different proliferative retinopathies due to different causes
Status | Completed |
Enrollment | 100 |
Est. completion date | December 2009 |
Est. primary completion date | November 2009 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 20 Years and older |
Eligibility |
Inclusion Criteria: - clinical diagnosis of a proliferative retinopathy (AGE RELATED MACULAR DEGENERATION,DIABETIC PROLIFERATIVE RETINOPATHY, etc) - distance acuity < 0.5 - age > 20 years Exclusion Criteria: - noncooperative patients - ocular infections / inflammations |
Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Romania | Ochiul Diabetic | Iasi |
Lead Sponsor | Collaborator |
---|---|
Ophthalmological Association Edelweiss |
Romania,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The following parameters will be assessed in order to evaluate the Avastin effect: visual acuity, lesions's area at the ocular fundus | one year | Yes | |
Secondary | The intraocular pressure will be measured during the whole study in order to assess the possible side effects of Avastin injections | one year | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05650047 -
Home OCT Guided Management Study of Subjects Diagnosed With Neovascular-AMD
|
||
Recruiting |
NCT05130385 -
High Resolution Optical Coherence Tomography
|
||
Recruiting |
NCT03211741 -
Longterm Efficiency and Safety of Intravitreal Injections With Bevacizumab in Patients With Neovascularisation or Macular Edema
|
Phase 4 | |
Recruiting |
NCT02486484 -
Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection
|
Phase 2 | |
Terminated |
NCT02088151 -
Selective Retinal Pigment Epithelium Laser Therapy for Macular Disease of the Retina
|
N/A | |
Completed |
NCT02876198 -
Study of the Modification of the Retinal Nerve Fiber Layer in Patients Treated With Intravitreous Injection of Anti-VEGF
|
||
Completed |
NCT01024998 -
Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
|
Phase 1 | |
Completed |
NCT01769183 -
Squalamine for the Treatment in Proliferative Diabetic Retinopathy
|
Phase 2 | |
Completed |
NCT01102946 -
Panretinal Photocoagulation (PRP) Plus Ranibizumab for Proliferative Diabetic Retinopathy
|
Phase 2 | |
Completed |
NCT04650672 -
Daily Testing at Home by NV-AMD Subjects With Notal Home OCT.
|
||
Completed |
NCT01494805 -
Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular Degeneration
|
Phase 1/Phase 2 | |
Completed |
NCT00000153 -
Krypton-Argon Regression of Neovascularization Study (KARNS)
|
Phase 3 |